Key figures
Key figures from the annual report.
Key figures 2011
Budget summary |
M.Ikr |
---|---|
Revenue |
462 |
Expenditure |
424 |
Staff |
322 |
Balance |
37.8 |
Human Resources: | |
---|---|
Staff |
Number |
Total staff |
56 |
Total fulltime posts |
49 |
Staff turnover |
9,5% |
Professions |
Number |
MCP |
1 |
Chemists |
2 |
Dentist |
1 |
Phycisians |
4 |
Buisness administration |
2 |
Pharmacy technicians |
10 |
Pharmacists |
20 |
Nurse |
1 |
IT expert |
1 |
Attorney at law - Advocate |
2 |
Medicinal Chemists |
3 |
Biochemist |
1 |
Pharmacologists |
1 |
Ms.eng.Biotechnologists |
1 |
Others |
4 |
Gender |
Number |
Female |
37 |
Male |
18 |
Average age |
44 years |
Visits to website | |
---|---|
Home page |
177.279 |
New users of home page |
41.240 |
National formulary |
246.956 |
New users of national formulary | 39.144 |
The Pharmaceutical Market |
|
---|---|
Industry |
Number |
Industry |
12 |
Wholesalers |
10 |
Pharmacies, pharmacy branches, physicians' outlets |
96 |
Others |
2 |
Hospitals, Nursing homes and Health clinics |
143 |
Veterinarians |
75 |
Average Pharmacy in Iceland |
Number |
Opening hours per week |
53.3 |
Prescriptions per year |
40.114 |
Pharmacists |
1.4 |
Pharmacy technician |
0.7 |
Other employees |
2.2 |
ATC | Cost and DDD |
M. Ikr* |
DDD/1000 inh./day |
---|---|---|---|
A | Alimentary tract and metabolism |
1.528 |
162.7 |
B | Blood and blood forming organs |
956 |
112.7 |
C | Cardiovascular system |
1.426 |
384 |
D | Dermatologicals |
370 |
74 |
G | Genito urinary system and sex hormones |
998 |
128.9 |
H | System hormonal preparations excluding sex hormones |
402 |
38.7 |
J | General antiinfectives, systemic |
1.722 |
23.8 |
L | Antineoplastic and immunomoduling agents |
3.221 |
13.2 |
M | Musculo-skeletal system |
615 |
89.5 |
N | Central nervous system |
4.168 |
339.9 |
P |
Antiparasitica |
29 |
1.4 |
R | Respiratory system |
1.101 |
120.6 |
S | Sensory organs |
239 |
9.8 |
V | Various |
181 |
0.0 |
Wholesale price without VAT |
|
|
Highest Turnover in Medicinal Products |
M. Ikr |
---|---|
Remicade |
667.3 |
Pariet |
328.7 |
Privigen |
301.6 |
Concerta |
297.2 |
Enbrel |
275.8 |
Humira |
232.9 |
Tysabri |
217.6 |
Seretide Diskus |
212.2 |
Helixate NexGen |
210.2 |
MabThera |
209.3 |
Wholesale price without VAT |
|
Licencing Unit |
|
---|---|
Marketing authorisation and applications |
Number |
Marketing authorisations |
4.864 |
New marketing authorisations |
596 |
Renewals |
550 |
Withdrawals |
317 |
Inspection Unit |
|
---|---|
Overview |
Number |
Inspections |
50 |
Inspected Medicinal Products on the market |
3 |
Certificates issued |
171 |
Classification of products |
26 |
Rapid Alerts |
130 |
Circulars |
0 |
Inspections |
|
Industry |
8 |
Pharmacies and pharmacy branches |
31 |
Wholesalers |
1 |
Health institutions and hospital pharmacies |
2 |
Veterinarians |
5 |
Other inspections |
3 |
Total |
50 |
Adverse reactions |
Number of reports |
Human Medicinal Products |
253 |
Veterinary Medicinal Products |
0 |
Clinical trials |
Number |
Commercial |
9 |
Non commercial |
0 |